At normal therapeutic doses (up to 3,0004,000 mg/day in adults), hepatic glutathione stores are typically adequate for NAPQI neutralization and rapid regeneration
The limited sample size and the insufficient duration of exposure could well explain the lack of significant results for all the other obesityrelated cancers, despite the relevant weight loss induced by GLP1RA
It triggers the release of insulin, which helps to regulate blood sugar levels, slow digestion and increase feelings of fullness.[1][2] These effects are why GLP-1-based medications (such as Mounjaro and Ozempic) have become so widely used in the management of type 2 diabetes and weight loss
However, recent comprehensive studies are challenging this belief and providing clarity for both patients and healthcare providers
Further evidence of the innate effect on neurons goes with the mentioned BPC 157 application, which increased both the survival rate of cultured enteric neurons and the proliferation of cultured enteric glial cells (EGCs) [119]